October 30, 2015
Allergan, Pfizer in merger talks
Allergan plc has confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
October 29, 2015
Novartis Foundation and partners launch new hypertension program in Ghana
The Novartis Foundation and its partners have begun screening patients in the Community-based Hypertension Improvement Project (ComHIP), a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control in Ghana
October 29, 2015
FDA approved BMS’s Yervoy
U.S. Food and Drug Administration (FDA) has approved BMS’s Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection including total lymphadenectomy.
October 28, 2015
Plandai in agreement with Bal Pharma for Phytofare
Plandaí Biotechnology, Inc., has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients.
October 28, 2015
GlaxoSmithKline exercises option for BioMedica’s LentiVector non-exclusive patents
Oxford BioMedica plc, a gene and cell therapy group, has announced that GlaxoSmithKline PLC (GSK) has exercised an option to obtain a non-exclusive licence for two rare orphan disease indications under Oxford BioMedica’s LentiVector platform technology patents.
October 28, 2015
Premaitha Health: Dr William Denman to join the Board as an Executive Director
Premaitha Health PLC, developer of the IONA test, the first CE-marked non-invasive prenatal screening test (NIPT) confirms that Chief Medical Officer, Dr William Denman, will join the Board of Premaitha as an Executive Director on 1 November 2015.
October 27, 2015
Health care costs for dementia found greater than for any other disease
In the last five years of life, total health care spending for people with dementia was more than a quarter-million…
October 27, 2015
GW Pharmaceuticals signs MOU to research Epudiolex with New South Wales (Australia)
GW Pharmaceuticals plc, has signed a Memorandum of Understanding (MOU) with the Government of New South Wales (NSW) in Australia to progress a research program for Epidiolex (cannabidiol or CBD) and cannabidivarin (CBDV) in children with severe, drug resistant childhood epilepsy.
October 27, 2015
Allergan Acquires Rights To Ironwood’s Constella
Allergan plc and Ironwood Pharmaceuticals, Inc. have announced that Allergan has acquired rights to Constella (linaclotide) in the European Union, Switzerland, Turkey and the Commonwealth of Independent States from Almirall, S.A. and has also reacquired rights to Linzess (linaclotide) in Mexico from Almirall.
October 26, 2015
Strensiq: First approved treatment for perinatal
Strensiq is the first treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP) approved approved by FDA.